Literature DB >> 16322949

A study of arteriosclerosis in healthy subjects with HBV and HCV infection.

Makoto Moritani1, Kyoichi Adachi, Noriyuki Arima, Toshiharu Takashima, Youichi Miyaoka, Masatoshi Niigaki, Kenji Furuta, Shuichi Sato, Yoshikazu Kinoshita.   

Abstract

BACKGROUND: It is unclear whether infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) affects arteriosclerosis. We performed a cross-sectional study to clarify the effect of HBV and HCV infection on arteriosclerosis.
METHODS: The study subjects were 1806 healthy individuals who visited Shimane Environment and Health Public Corporation for routine medical check-ups. Serum levels of total cholesterol, high-density lipoprotein (HDL)-cholesterol, triglycerides, and blood glucose were investigated in all subjects. The degree of arteriosclerosis was assessed using systolic blood pressure, the bilateral ankle brachial index (ABI), the heart-carotid pulse wave velocity (HCPWV), and the heart-ankle PWV (HAPWV). These cardiovascular parameters were compared between control subjects and subjects with HBV and HCV infection, using analysis of covariance to adjust for confounding factors (sex, age, body mass index, and smoking and drinking).
RESULTS: Of the 1806 subjects, 39 and 31 were diagnosed as positive for HBV and HCV infection, respectively. The remaining 1736 were considered to be the controls. Adjusted serum lipid levels in the subjects with HBV and those with HCV infection tended to be lower than those in the control subjects. Adjusted arteriosclerotic parameters in the subjects with HBV and HCV infection were similar to those in the control subjects, even after adjusting for serum lipid levels.
CONCLUSIONS: Infection with HBV or HCV does not influence the severity of arteriosclerosis in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322949     DOI: 10.1007/s00535-005-1655-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   6.772


  30 in total

1.  Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure.

Authors:  A P Guerin; J Blacher; B Pannier; S J Marchais; M E Safar; G M London
Journal:  Circulation       Date:  2001-02-20       Impact factor: 29.690

Review 2.  Warner-Lambert/Parke-Davis Award Lecture. Viral pathogenesis of atherosclerosis. Impact of molecular mimicry and viral genes.

Authors:  D P Hajjar
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

3.  Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Z J Zheng; A R Sharrett; L E Chambless; W D Rosamond; F J Nieto; D S Sheps; A Dobs; G W Evans; G Heiss
Journal:  Atherosclerosis       Date:  1997-05       Impact factor: 5.162

4.  Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations.

Authors:  R Asmar; A Rudnichi; J Blacher; G M London; M E Safar
Journal:  Am J Hypertens       Date:  2001-02       Impact factor: 2.689

5.  Association of virulent Helicobacter pylori strains with ischemic heart disease.

Authors:  V Pasceri; G Cammarota; G Patti; L Cuoco; A Gasbarrini; R L Grillo; G Fedeli; G Gasbarrini; A Maseri
Journal:  Circulation       Date:  1998-05-05       Impact factor: 29.690

6.  Aortic pulse wave velocity as a marker of cardiovascular disease in subjects over 70 years old.

Authors:  S Meaume; A Rudnichi; A Lynch; C Bussy; C Sebban; A Benetos; M E Safar
Journal:  J Hypertens       Date:  2001-05       Impact factor: 4.844

7.  Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease.

Authors:  C M Papamichael; J P Lekakis; K S Stamatelopoulos; T G Papaioannou; M K Alevizaki; A T Cimponeriu; J E Kanakakis; A Papapanagiotou; A T Kalofoutis; S F Stamatelopoulos
Journal:  Am J Cardiol       Date:  2000-09-15       Impact factor: 2.778

8.  Augmentation of central arterial pressure in type 1 diabetes.

Authors:  B Brooks; L Molyneaux; D K Yue
Journal:  Diabetes Care       Date:  1999-10       Impact factor: 19.112

9.  Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers.

Authors:  Nobukazu Ishizaka; Yuko Ishizaka; Eiko Takahashi; Ei-ichi Toda Ei; Hideki Hashimoto; Minoru Ohno; Ryozo Nagai; Minoru Yamakado
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

10.  Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity.

Authors:  Hiroki Yokoyama; Tomomi Aoki; Masumi Imahori; Masae Kuramitsu
Journal:  Kidney Int       Date:  2004-07       Impact factor: 10.612

View more
  6 in total

1.  Sonographic fatty liver and hepatitis B virus carrier status: synergistic effect on liver damage in Taiwanese adults.

Authors:  Yu-Cheng Lin; Shu-Tin Hsiao; Jong-Dar Chen
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

Review 2.  Association between hepatitis B and metabolic syndrome: Current state of the art.

Authors:  Peter Jarcuska; Sylvia Drazilova; Jan Fedacko; Daniel Pella; Martin Janicko
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

3.  Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients.

Authors:  Chung-Feng Huang; Ming-Yen Hsieh; Jeng-Fu Yang; Wu-Cheng Chen; Ming-Lun Yeh; Ching-I Huang; Chia-Yen Dai; Ming-Lung Yu; Zu-Yau Lin; Shinn-Chern Chen; Wan-Long Chuang; Jee-Fu Huang
Journal:  Hepatol Int       Date:  2010-08-04       Impact factor: 6.047

4.  Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B.

Authors:  Ho Soo Chun; Jae Seung Lee; Hye Won Lee; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Seung Up Kim
Journal:  Dig Dis Sci       Date:  2021-09-02       Impact factor: 3.487

5.  Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul study.

Authors:  Judith I Tsui; Mary A Whooley; Alexander Monto; Karen Seal; Phyllis C Tien; Michael Shlipak
Journal:  J Card Fail       Date:  2009-02-10       Impact factor: 5.712

6.  Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis.

Authors:  Yuanyuan Li; Ying Zhao; Jianping Wu
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.